JAK/TYK2
1 month 1 week ago
Pain in PsA = predictor of disability and QoL
TYK-2 inhibition lowered clinical pain outcomes and ALSO pain-associated biomarkers vs PBO
@RheumNow #ACR24 Abstract #2366 https://t.co/DAgmdmmTE0
1 month 1 week ago
Summary of treatments in psoriatic arthritis #PsA @RheumNow #ACR24 https://t.co/EybzRCPLtA
ACR 2024 starts tomorrow. Here are a few previews of abstracts to be presented, along with my recommendations of sessions you don’t want to miss.Previews:Abstract Number: 2527 Efficacy and…